SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Grommit who wrote (71216)9/27/2022 7:36:20 PM
From: E_K_S   of 78740
 
Re: Medical REITs; DOC & MPW

I got filled on my DOC order. In w/ shares in taxable account at $14.97/share, close to a 6% div.

I noticed I had this earlier in the year 9/1/2022 w/ a small starter position at $16.41 but sold it for a small gain (not sure why but it worked out).

DOC closed -2.5% at $14.85/share
----------------------------------------------------

I also started a small position in MPW 9/23/2022 at $12.27/share in the taxable account. It's also a medical REIT. Div yield is 9.3%

I have owned this in the ROTH & IRA since 2018 w/ some sells in 2/2021 at $22.35 & 12/2021 at $22.11. I made some Buys in 6/2022 at $14.40/share but might want to look at adding both MPW & DOC to the ROTH at the current price.

MPW closed -0.75% at $11.93/share

----------------------------------------

Medical Properties stock slips after Jefferies downgrades to Hold
Peterson has lowered his FFO estimates on the basis of lower net acquisition volumes as well as a rising interest rate environment, according to a note written to clients. Keep in mind that MPW has underperformed the broader REIT sector in previous tightening cycles given its bond-like structure.
As a result, the analyst has cut his 2022 FFO estimate to $1.82 compared with $1.84 in the prior forecast and the consensus of $1.86. For 2023, Peterson sees FFO at $1.86 vs. $1.89 in the previous view and the Wall Street estimate of $1.94. Through 2024, Peterson is expecting FFO per share to grow at a compounded annual growth rate of +2.8%, down from +8.7% achieved from 2019 through 2021, the note said.

Price target was also lowered to $20 per share, implying 1.6% downside from Thursday's close.
In mid-April, Medical Properties Trust was added as a new best short idea at Hedgeye.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext